We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
Cap. Flow
+$6.04B
Cap. Flow %
4.61%
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 8.26%
2 Financials 3.77%
3 Consumer Discretionary 2.12%
4 Communication Services 1.89%
5 Healthcare 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
3326
Western Union
WU
$2.57B
$240K ﹤0.01%
29,981
+712
+2% +$5.95K
TRVI icon
3327
Trevi Therapeutics
TRVI
$2.49B
$240K ﹤0.01%
26,175
+5,928
+29% +$44.5K
OPRA
3328
Opera Ltd
OPRA
$1.65B
$239K ﹤0.01%
11,585
+1,564
+16% +$27.9K
IAS
3329
DELISTED
Integral Ad Science
IAS
$239K ﹤0.01%
23,507
+8,808
+60% +$76.3K
RDIV icon
3330
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.36B
$239K ﹤0.01%
4,582
-398
-8% -$20K
IMXI icon
3331
International Money Express
IMXI
$392M
$238K ﹤0.01%
17,060
-9,939
-37% -$123K
DCO icon
3332
Ducommun
DCO
$2.68B
$238K ﹤0.01%
+2,479
New +$224K
BBW icon
3333
Build-A-Bear
BBW
$423M
$238K ﹤0.01%
+3,654
New +$215K
RGCO icon
3334
RGC Resources
RGCO
$229M
$238K ﹤0.01%
10,602
+66
+0.6% +$1.45K
CVAC
3335
DELISTED
CureVac
CVAC
$238K ﹤0.01%
44,121
-2,977
-6% -$16.1K
EZPW icon
3336
Ezcorp Inc
EZPW
$1.82B
$237K ﹤0.01%
12,472
+2,064
+20% +$32.3K
HRMY icon
3337
Harmony Biosciences
HRMY
$2.04B
$237K ﹤0.01%
+8,614
New +$297K
CCC
3338
CCC Intelligent Solutions
CCC
$3.42B
$237K ﹤0.01%
26,007
-9,237
-26% -$89.3K
BTO
3339
John Hancock Financial Opportunities Fund
BTO
$802M
$237K ﹤0.01%
+6,578
New +$238K
VLGEA icon
3340
Village Super Market
VLGEA
$631M
$236K ﹤0.01%
+6,310
New +$232K
INMD icon
3341
InMode
INMD
$872M
$236K ﹤0.01%
15,808
-3,221
-17% -$47.1K
FQAL icon
3342
Fidelity Quality Factor ETF
FQAL
$1.41B
$235K ﹤0.01%
3,146
-126
-4% -$9.08K
WSFS icon
3343
WSFS Financial
WSFS
$4.1B
$235K ﹤0.01%
+4,356
New +$246K
MAYW icon
3344
AllianzIM U.S. Equity Buffer20 May ETF
MAYW
$444M
$235K ﹤0.01%
7,128
IIIN icon
3345
Insteel Industries
IIIN
$633M
$235K ﹤0.01%
+6,125
New +$231K
INSP icon
3346
Inspire Medical Systems
INSP
$1.42B
$235K ﹤0.01%
3,164
+371
+13% +$37.6K
BKN
3347
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$235K ﹤0.01%
20,699
+7,900
+62% +$86.1K
ABUS icon
3348
Arbutus Biopharma
ABUS
$865M
$235K ﹤0.01%
51,692
-1,246
-2% -$4.58K
DFH icon
3349
Dream Finders Homes
DFH
$1.46B
$234K ﹤0.01%
9,028
+832
+10% +$22.9K
PRCH icon
3350
Porch Group
PRCH
$1.3B
$234K ﹤0.01%
13,935
+2,385
+21% +$36.6K

Similar funds

Creative Planning's Q3 2025 Portfolio in Review

As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.

  • Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
  • Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
  • Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
  • Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
  • Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
  • Creative Planning opened 364 new positions and closed 133 in Q3 2025.
  • Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.